Emond, Jean-Philippe
Lacombe, Louis https://orcid.org/0000-0003-4811-0308
Caron, Patrick
Turcotte, Véronique
Simonyan, David
Aprikian, Armen
Saad, Fred
Carmel, Michel
Chevalier, Simone
Guillemette, Chantal https://orcid.org/0000-0002-1113-1212
Lévesque, Eric https://orcid.org/0000-0001-5986-3458
Article History
Received: 18 January 2021
Revised: 8 March 2021
Accepted: 16 March 2021
First Online: 7 April 2021
Ethics approval and consent to participate
: All participants provided written informed consent and the CHU de Quebec research ethics committee approved the research protocol, and the study was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The datasets analysed during this study are available from the corresponding author on reasonable request.
: The authors declare no competing interests.
: This work was supported by research grants from Prostate Cancer Canada (D2013-22 to E.L., C.G. and L.L.), the Cancer Research Society (to C.G.) and the Canada Research Chair Program (to C.G.). E.L. holds a CIHR Clinician-Scientist Award and was the holder of the PCC rising star award (RS2013-59). C.G. holds the Canada Research Chair in Pharmacogenomics (Tier I). The results are based on samples and patient data obtained from the PROCURE Biobank, supported by donations in a partnership with the Cancer Research Society of Canada.